risankizumab
abbvie
['risan', 'ibd']
conclusion: subcutaneous risankizumab was efficacious in patients with delayed response to iv risankizumab induction #uegweek #ibd #gitwitter 
The Lancet Gastroenterology & Hepatology publishes high-quality peer-reviewed research and reviews, comment, and news #gastroenterology #hepatology. IF=45.042